Objects
Andersen, Johanna B., Sharmin, Sifat, Lefort, Mathilde, Koch-Henriksen, Nils, Sellebjerg, Finn, Sørensen, Per Soelberg, Hilt Christensen, Claudia C., Rasmussen, Peter V., Jensen, Michael B., Frederiksen, Jette L., Bramow, Stephan, Mathiesen, Henrik K., Schreiber, Karen I., Horakova, Dana, Havrdova, Eva K., Alroughani, Read, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Patti, Francesco, Onofrj, M, Lugaresi, A, Terzi, M, Grammond, P, Grand Maison, F, Yamout, B, Prat, A, Girard, M, Duquette, P, Boz, C, Trojano, M, McCombe, P, Slee, M, Lechner-Scott, Jenette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Shaygannejad, V, Prevost, J, Skibina, O, Solaro, C, Karabudak, R, Wijmeersch, BV, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Ciron, J, Ruet, A, Sèze, JD, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun, C, Moreau, T, Berger, E, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanché, JP, Marousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Leray, E, Laplaud, DA, Butzkueven, H, Kalincik, T, Vukusic, S, Magyari, M. Elsevier; 2021. The effectiveness of natalizumab vs fingolimod - A comparison of international registry studies.
De Brouwer, Edward, Becker, Thijs, Kappos, Ludwig, Sola, Patrizia, Cartechini, Elisabetta, Lechner-Scott, Jeannette, Alroughani, Raed, Gerlach, Oliver, Kalincik, Tomas, Granella, Franco, Grand'Maison, Francois, Bergamaschi, Roberto, Moreau, Yves, José Sá, M, Van Wijmeersch, B, Soysal, A, Sanchez-Menoyo, JL, Solaro, C, Boz, C, Iuliano, G, Buzzard, K, Aguera-Morales, E, Terzi, M, Havrdova, Eva Kubala, Trivio, TC, Spitaleri, D, Van Pesch, V, Shaygannejad, V, Moore, F, Oreja-Guevara, C, Maimone, D, Gouider, R, Csepany, T, Ramo-Tello, C, Trojano, Maria, Peeters, L, Eichau, Sara, Ozakbas, Serkan, Onofrj, Marco, Grammond, Pierre, Kuhle, Jens. Elsevier; 2021. Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression.
Roos, Izanne, Leray, Emmanuelle, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Frascoli, Federico, Sá, Maria José, Cartechini, E, Boz, C, Granella, F, Hupperts, R, Terzi, M, Lechner-Scott, Jeannette, Spitaleri, D, Van Pesch, V, Soysal, A, Casey, Romain, Olascoaga, J, Prevost, J, Aguera-Morales, E, Slee, M, Csepany, T, Turkoglu, R, Sidhom, Y, Gouider, R, Van Wijmeersch, B, McCombe, P, Brown, J. William L., Macdonell, R, Coles, A, Malpas, CB, Butzkueven, H, Vukusic, S, Kalincik, T, , , Horakova, Dana, Havrdova, Eva K., Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo. Oxford University Press; 2020. Delay from treatment start to full effect of immunotherapies for multiple sclerosis.
Roos, Izanne, Leray, Emmanuelle, Izquierdo, Guillermo, Eichau, Sara, Edan, Gilles, Prat, Alexandre, Girard, Marco, Duquette, Pierre, Onofrj, Marco, Lugaresi, Alessandra, Grammond, Pierre, Ciron, Jonathon, Frascoli, Federico, Ruet, A, Ozakbas, S, De Seze, J, Louapre, C, Zephir, H, Sá, MJ, Sola, P, Ferraro, D, Labauge, P, Defer, G, Casey, Romain, Bergamaschi, R, Lebrun-Frenay, C, Boz, C, Cartechini, E, Moreau, T, Laplaud, D, Lechner-Scott, Jeanette, Grand’Maison, F, Gerlach, O, Terzi, M, Brown, J. William L., Granella, F, Alroughani, R, Iuliano, G, Van Pesch, V, Van Wijmeersch, B, Spitaleri, DLA, Soysal, A, Berger, E, Prevost, J, Aguera-Morales, E, Horakova, Dana, McCombe, P, Castillo Triviño, T, Clavelou, P, Pelletier, J, Turkoglu, R, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Sidhom, Y, Havrdova, Eva Kubala, Gouider, R, Csepany, T, Bourre, B, Al Khedr, A, Casez, O, Cabre, P, Montcuquet, A, Wahab, A, Camdessanche, JP, Maurousset, A, Debouverie, Marc, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Coles, A, Malpas, CB, Vukusic, S, Butzkueven, H, Trojano, Maria, Kalincik, T, Patti, Francesco. Sage Publications; 2021. Determinants of therapeutic lag in multiple sclerosis.
Fambiatos, Adam, Jokubaitis, Vilija, Grand'Maison, Francois, Grammond, Pierre, Sola, Patricia, Ferraro, Diana, Alroughani, Raed, Terzi, Murat, Hupperts, Raymond, Boz, Cavit, Lechner-Scott, Jeannette, Pucci, Eugenio, Horakova, Dana, Bergamaschi, Roberto, Van Pesch, V, Ozakbas, S, Granella, F, Turkoglu, R, Iuliano, G, Spitaleri, D, McCombe, P, Solaro, C, Slee, M, Kubala Havrdova, Eva Kubala, Ampapa, R, Soysal, A, Petersen, T, Sanchez-Menoyo, JL, Verheul, F, Prevost, J, Sidhom, Y, Van Wijmeersch, B, Vucic, S, Cristiano, E, Trojano, Maria, Saladino, ML, Deri, N, Barnett, M, Olascoaga, J, Moore, F, Skibina, O, Gray, O, Fragoso, Y, Yamout, B, Shaw, C, Prat, Alexandre, Singhal, B, Shuey, N, Hodgkinson, S, Altintas, A, Al-Harbi, T, Csepany, T, Taylor, B, Hughes, J, Jun, J-K, van der Walt, A, Girard, Marc, Spelman, T, Butzkueven, H, Kalincik, T, Duquette, Pierre, Lugaresi, Alessandra, Izquierdo, Guillermo. Sage; 2020. Risk of secondary progressive multiple sclerosis: a longitudinal study.
Sharmin, Sifat, Lefort, Mathilde, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand'Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Andersen, Johanna Balslev, Trojano, Maria, McCombe, P, Slee, M, Lechner-Scott, Jeannette, Turkoglu, R, Sola, P, Ferraro, D, Granella, F, Prevost, J, Maimone, D, Leray, Emmanuelle, Skibina, O, Buzzard, K, Van der Walt, A, Van Wijmeersch, B, Csepany, T, Spitaleri, D, Vucic, S, Casey, R, Debouverie, M, Edan, G, Horakova, Dana, Ciron, J, Ruet, A, De Seze, J, Maillart, E, Zephir, H, Labauge, P, Defer, G, Lebrun-Frenay, C, Moreau, T, Berger, E, Havrdova, Eva Kubala, Clavelou, P, Pelletier, J, Stankoff, B, Gout, O, Thouvenot, E, Heinzlef, O, Al-Khedr, A, Bourre, B, Casez, O, Cabre, P, Alroughani, Raed, Montcuquet, A, Wahab, A, Camdessanche, J-P, Maurousset, A, Patry, I, Hankiewicz, K, Pottier, C, Maubeuge, N, Labeyrie, C, Nifle, C, Izquierdo, Guillermo, Laplaud, D, Koch-Henriksen, N, Sellebjerg, FT, Soerensen, PS, Pfleger, CC, Rasmussen, PV, Jensen, MB, Frederiksen, JL, Bramow, S, Mathiesen, HK, Ozakbas, Serkan, Schreiber, KI, Magyari, M, Vukusic, S, Butzkueven, H, Kalincik, T, Patti, Francesco. Adis International; 2021. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts.